10 Best CEFs This Month: Average Yield Of 10% (September 2026)Seeking Alpha · Sep 26, 2026
HQL: The Rally That Makes Growth Harder (Rating Downgrade)Seeking Alpha · Sep 15, 2026
10 Best CEFs This Month: Average Yield Of Near 10% (August 2026)Seeking Alpha · Aug 29, 2026
10 Best CEFs This Month: Average Yield Of Near 10% (July 2026)Seeking Alpha · Jul 25, 2026Tekla Life Sciences Investors, a closed-ended equity mutual fund, is expertly managed by Tekla Capital Management LLC. This U.S.-domiciled fund, which commenced operations on February 20, 1992, and was formerly known as H&Q Life Sciences Investors, seeks investment opportunities in publicly traded companies worldwide. Its primary focus lies within the broad life sciences sector, encompassing a diverse range of industries such as biotechnology, pharmaceuticals, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, and medical devices and supplies.